Krystal Biotech: BofA Global Research cuts price objective to $390 from $400
KRYS•BofA Global Research cut its price objective for Krystal Biotech to $390 from $400.
Related News
Cboe Global Markets price objective raised to $350 from $329
CBOE•
Palantir Technologies raises target price to $235 from $231
PLTR•
AI productivity gains could add $28 billion-$84 billion to India’s annual GDP, Cognizant study finds
CTSH•
Piper Sandler cuts Axsome Therapeutics target price to $235 from $238
AXSM•
Imperial Oil: TD Cowen raises target price to C$164 from C$158
IMO•